Guardant Health: Leveraging Liquid Biopsy Testing Momentum [Seeking Alpha]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
GH delivered FY2025 revenue of $982 million, up 33% YoY, with oncology contributing 67.6% of total revenues and 26% YoY growth. Liquid biopsy adoption is accelerating, offering non-invasive cancer diagnostics and supporting GH's revenue momentum and market outperformance. Despite sustained operating losses, GH is positioned for continued top-line growth, with FY2026 revenue estimated at $1.27 billion and a potential price target of $109.57. anamejia18/iStock via Getty Images Investment Thesis and Introduction We are in the 2 nd quarter of the year 2026, and you notice that in my previous article, my rating for Guardant Health, Inc. ( GH ) was bullish, driven This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of GH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no bu
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know [Yahoo! Finance]Yahoo! Finance
- Guardant Health (GH) Valuation Check After Strong 1 Year Return And Recent 90 Day Pullback [Yahoo! Finance]Yahoo! Finance
- 1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds [Yahoo! Finance]Yahoo! Finance
- Why Is Guardant Health (GH) Stock Soaring Today [Yahoo! Finance]Yahoo! Finance
- Guardant Health's InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 2/19/26 - Beat
GH
Sec Filings
- 4/7/26 - Form 4
- 4/6/26 - Form 144
- 4/2/26 - Form 4
- GH's page on the SEC website